250mg Gefitinib Tablets

Get a Price/Quote

MOQ : 10 Boxes

250mg Gefitinib Tablets Specification

Salt Composition
Gefitinib 250mg

Dosage Form
Tablet

Indication
Non-Small Cell Lung Cancer (NSCLC)

Feature
Oral, targeted therapy, Oral targeted therapy, EGFR tyrosine kinase inhibitor

Ingredients
Gefitinib, Excipients, Gefitinib, Excipients

Application
Anticancer therapy, EGFR inhibitor, Oncology, lung cancer treatment

Physical Color/Texture
White to off-white, round film-coated tablets, White to off-white, round tablet

Fermentation Smell
Odorless

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Shelf Life
24-36 months

Storage Condition
Keep out of reach of children, store in original packaging

Common Side Effects
Rash, diarrhea, nausea, vomiting, loss of appetite

Pack Size
10 tablets per strip (custom pack sizes available)

Patient Suitability
Adults only, not for pediatric use

Regulatory Approval
Marketed in accordance with applicable local approvals and regulatory standards

Marketed By
As per packaging information

Prescription Status
Prescription-only medicine

Brand Names
Varies (examples: Iressa, Geftinat, Geftib, etc.)

Strength
250mg

Pharmacotherapeutic Group
Antineoplastic agents, protein kinase inhibitors

Synthetic/Herbal/Other
Synthetic

Administration Route
Oral

ATC Code
L01XE02

Dose Frequency
Once daily or as directed by physician

Packaging Type
Blister strip or bottle pack

250mg Gefitinib Tablets Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

250mg Gefitinib Tablets About

Get inestimable value for your oncology regimen with 250mg Gefitinib Tablets. Designed as an oral, prescription-only EGFR inhibitor, these tablets deliver top therapeutic potency against Non-Small Cell Lung Cancer (NSCLC) in adults. Each dose radiates reliability in a lustrous white to off-white, round film-coated tablet. Available in blister strips or bottle packs-10 tablets per strip or custom sizes-Gefitinib exemplifies targeted cancer therapy. Redeem peace of mind: each batch is kept within regulatory standards, boasting a shelf life of 24-36 months. Store cool, dry, and protected.

Surface of Application, Area of Application, and Competitive Advantages

250mg Gefitinib Tablets are intended for oral administration, providing a convenient route for targeted anticancer therapy. The main area of application is in the management of Non-Small Cell Lung Cancer (NSCLC) in adult patients. A standout advantage lies in its targeted mechanism as an EGFR tyrosine kinase inhibitor, ensuring focused treatment with reduced systemic exposure. This radiantly efficient approach leads to enhanced patient outcomes and positions Gefitinib at the top of modern oncological therapies.

Sample Policy, Packaging Details, and Payment Terms

Sample requests for 250mg Gefitinib Tablets can be estimated based on availability and order size. Packaging delivers flexibility-choose blister strips or bottle packs with standard or custom counts. Orders are carefully protected against light and moisture, ensuring safe arrival. Delivery timelines and payment terms are determined upon order completion, providing transparency and reliability for every transaction. Export and trader agreements are supported for global clients with secure, compliant shipment practices.

FAQ's of 250mg Gefitinib Tablets:

Q: How should 250mg Gefitinib Tablets be used for optimal benefit?

A: Take one tablet orally once daily, or follow your physician's specific instructions regarding dosage and frequency for effective treatment.

Q: What are the common side effects associated with Gefitinib?

A: Patients may experience rash, diarrhea, nausea, vomiting, and a loss of appetite. Always consult your doctor for tailored management of side effects.

Q: When is Gefitinib indicated for therapy?

A: Gefitinib is indicated primarily for adults diagnosed with Non-Small Cell Lung Cancer (NSCLC) and prescribed as part of their anticancer therapy.

Q: Where should I store Gefitinib tablets at home?

A: Keep Gefitinib in its original packaging at a cool, dry place below 30C, away from children, light, and moisture to retain its efficacy.

Q: What is the process for redeeming sample tablets or completing an order?

A: Contact the supplier or exporter to estimate sample availability. Upon confirmation, finalize packaging preferences and payment terms to initiate delivery.

Q: What benefits does Gefitinib offer over non-targeted therapies?

A: As an EGFR-targeted tyrosine kinase inhibitor, Gefitinib provides focused cancer treatment, potentially reducing systemic side effects compared to conventional therapies.

Tell us about your requirement